Show results for
Refine by
Central Nervous System Suppliers Serving Norway
80 companies found
based inParis, FRANCE
Qynapse, through QyScore, brings groundbreaking peace of mind to the global fight against CNS disease. Qyscore is a medical device software FDA-cleared – class II and CE-marked – class IIa (CE BSI). Qyscore is a medical device software FDA-cleared ...
The software is intended to be used by medical personnel or neuroimaging trained personnel to support diagnosis of central nervous system diseases. Available for research use only and protected by 3 ...
based inYongin-si, SOUTH KOREA
Vivozon is a global innovative drug development company established in 2008. We built an efficacy-based new drug discovery system that is clearly distinct from the existing new drug development paradigm, and discovered the non- narcotic analgesic ...
Opiranserin (VVZ-149) for injection is a first-in-class non-narcotic analgesic under development by Vivozon. As atreatment for postoperative pain used as a first-line therapy in the global market, Opiranserin aims to ultimately replaceopioid ...
based inBangkok, THAILAND
The Regeneration Center provides comprehensive and scientifically backed stem cell treatments for numerous conditions and degenerative diseases. Through years of research and clinical applications of modern cellular therapeutics our internationally ...
Dental pulp stem cells derived (DPSCs) represents a new and exciting alternative source of adult stem cells for use in regenerative medicine. The DPSCs are considered very unique because the cells are relatively easy acquire in an extremely safe and ...
based inHolte, GERMANY
ACTO GmbH was founded in Braunschweig, Germany in 1990. As of today, our headquarter and the factory is located in Wietzen-Holte, Germany, and other branches in Braunschweig, Bavaria, and Baden-Württemberg in Germany. Specialized in hygiene, ...
Actolind® w Solution is a cleansing, irrigation, decontamination, moistening and care solution used together with materials such as bandages, dressings, pads and wound fillers for acute, chronic and infected wounds as well as 1st and 2nd degree ...
based inTaipei, TAIWAN
APrevent is a medical device company, founded in 2013 by a team of international clinically experienced physicians and engineers. APrevent's products improve voice and communication, focusing on the development of a long- term implant system and ...
Speech conversion platform for speech disorder (dysarthria) patients, Real-time speech-to-speech conversion, Easy and convenient hands-free operation, Speech conversion without limitation of vocabularies, Customized needs with individualized ...
based inEncinitas, CALIFORNIA (USA)
Neurodigitech (NDT) is dedicated to 1) Neurohistological and neuropathological services of the central nervous system (CNS), 2) Neural staining kits, 3) High-throughput digital microscopic imaging and stereology-based quantitative morphology, and 4) ...
This innovated method will help researchers able to simultaneously visualize (a) the structural detail, (b) the antigen’s characterization, (c) the anatomical interaction between discrete neuronal elements, and (d) the 3D reconstruction and ...
based inShirley, MASSACHUSETTS (USA)
In 2022, we became part of Absolute Biotech, a new company that unites multiple life science brands into one organization specializing in antibody reagents and services. Learn more at absolutebiotech.com. The extensive LSBio reagent catalog contains ...
LTB4R2 is a low-affinity receptor for leukotrienes including leukotriene B4. It mediates the chemotaxis of granulocytes and macrophages. The response is mediated via G-proteins that activate a phosphatidylinositol-calcium second messenger system. ...
based inBerwyn, PENNSYLVANIA (USA)
Virpax Pharmaceuticals specializes in developing novel and proprietary drug-delivery systems across various pain and CNS disorder indications to enhance compliance and to optimize the efficacy of each product candidate. Our transforming ...
Benefits: NobrXiol may be using significantly less pharmaceutical-grade CBD than current FDA approved oral CBD dosing. NobrXiol may achieve higher efficiency via the nasal route and reduce peripheral side effects like dose dumping due to high-fat ...
based inShanghai, CHINA
Established in September 2017, Siyi Intelligence is a high-tech company engaged in the research and development, production and sales of rehabilitation robotic system. Based in Shanghai of China, Siyi is specialized in providing the innovative ...
Who we are? Shanghai Siyi intelligent Technology Co.,Ltd is a high-tech enterprise specializing in the development of medical rehabilitation robots. It is committed to continuously creating a series of intelligent rehabilitation equipment from ...
based inHaifa, ISRAEL
Good Energies Ltd. is an international company (founded in 2009) which develops, markets and distributes the B-Cure Laser products. Designed to treat pain, orthopedic disorders, wounds and inflammations, for daily domestic use in the comfort of ...
Lower back pain is one of the main causes of difficulty in everyday, routine functions. Pain in the lower back is the most common form of work-related disability and the main reason for absence from work. Eight out of ten people in the United States ...
based inResearch Triangle Park, NORTH CAROLINA (USA)
Galaxy Diagnostics was launched in 2009 to commercialize a more sensitive test method for Bartonella species infection, called Bartonella ePCR. The underlying technology, developed by Galaxy cofounders, Drs. Ed Breitschwerdt and Ricardo Maggi at NC ...
When Bartonella bacteria are present in the body, the immune system creates antibodies that help eliminate them. Test methods, such as immunofluorescence assays (IFA), determine the level of IgM and/or IgG antibodies circulating in a patient, which ...
based inPlanegg, GERMANY
ViGeneron is based on our passion to deliver gene therapy innovations and advances to people in need. Our proprietary science solves major limitations in current gene therapy approaches. At ViGeneron we are dedicated to developing innovative gene ...
vgAAV, ViGeneron’s proprietary AAV Vector platform, is our next generation vector platform based on novel engineered AAV capsids. In a unique in vivo directed-evolution approach we generated our vgAAV vectors. The vgAAV vector platform enables ...
based inMississauga, ONTARIO (CANADA)
Award-winning, Clinical Stage/Life-Sciences company focused on the drug discovery and development of next-generation targeted therapeutics within the endocannabinoid system and specific brain receptors. The company is targeting anxiety, depression, ...
The Endocannabinoid System is a complex system within the body that sends signals to the cells. There are three major parts to the system, enzymes, receptors, and endocannabinoids. The body makes these molecules. Endocannabinoids are similar to ...
based inMumbai, INDIA
Lupin is a global pharmaceutical company offering a wide range of products such as Branded & Generic Formulations, Biotechnology Products, Active Pharmaceutical Ingredients (APIs) and Specialty. Lupin is a significant player in the therapy areas of ...
based inAncaster, ONTARIO (CANADA)
The Actlabs Group of Companies provides contract analytical services covering all aspects of analysis from academic research applications to routine quality control functions. We provide our services to many fields, including Geochemical, ...
ActLabs Biotech scientists can assist with innovative biomarker assay development and validation. To compliment our range of immunoassays, we also offer LC-MS/MS technology that has enabled us to extend our portfolio to include more biomarkers. In ...
based inKyiv, UKRAINE
Darnitsa is the leader of the Ukrainian market in physical terms. 90 years of experience and GMP production certification have allowed us to earn confidence in 16 countries worldwide. We produce 180 products with a focus on cardiology, neurology, ...
Symbiia® - for treatment of major depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety ...
based inNew York City, NEW YORK (USA)
Lauren Sciences is a privately-held New York biotechnology company focused on developing its V-Smart platform to create a robust pipeline of V-Smart therapeutics consisting of central nervous system (CNS)-active drugs that normally do not cross the ...
V-Smart Platform, breakthrough innovation, winning trifecta for brain delivery, enables non-invasive, triple-targeted CNS delivery of non-BBB penetrant therapeutic agents (nucleic acids, antibodies, biologics, small molecules, ...
based inCoral Gables, FLORIDA (USA)
We are a late-stage biotech company addressing diseases of the central nervous system (CNS), with a focus on major depressive disorder (MDD). Our experienced and dedicated team is committed to making a difference in the lives of patients and their ...
based inSalt Lake City, UTAH (USA)
BioFire Diagnostics sets the standard for molecular diagnostics through its pioneering advances in syndromic infectious disease testing. As BioMérieux’s Global Center of Excellence for Molecular Diagnostics, no other company has FDA-cleared and ...
Distinguishing bacterial from viral meningitis based on clinical presentation is challenging. Patients often present with similar, flu-like ...
based inVancouver, BRITISH COLUMBIA (CANADA)
InMed Pharmaceuticals is a global leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, including clinical and preclinical programs targeting the treatment of diseases with high unmet ...
INM-755 is a cannabinol topical cream under development for the treatment of epidermolysis bullosa. INM-755 cream for EB is the first, and currently the only, cannabinol formulation being tested in clinical trials as a therapeutic ...